Aflac AFL Cancer — Deferred policy acquisition costs

Other product segments

Similar metrics at other companies

PRADeferred policy acquisition costs

$60.34M-1.5%

SPNTDeferred policy acquisition costs

$403.4M+9.2%

AXSDeferred policy acquisition costs

$933.8M+49.1%

ASI

ASICDeferred policy acquisition costs

$33.84M+37.1%

HGDeferred policy acquisition costs

$291.31M+20.2%

EIGDeferred policy acquisition costs

$57.1M-10.5%

Questions, answered.

What is Aflac's cancer — deferred policy acquisition costs?

Aflac (AFL) reported cancer — deferred policy acquisition costs of $2.94B in Q1 2026.

How has Aflac's cancer — deferred policy acquisition costs changed year-over-year?

Aflac's cancer — deferred policy acquisition costs decreased by 0.5% year-over-year, from $2.95B to $2.94B.

What is the long-term trend for Aflac's cancer — deferred policy acquisition costs?

Over 2 years (2023 to 2025), Aflac's cancer — deferred policy acquisition costs has grown at a 1.8% compound annual growth rate (CAGR), from $11.64B to $12.06B.

What does cancer — deferred policy acquisition costs mean?

Represents the unamortized portion of costs directly related to the acquisition of new insurance policies within the cancer segment. These costs are capitalized and amortized over the expected life of the policies to match expenses with related premium revenues.